7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
about
The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradicationTreatment of Helicobacter pylori infection.Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections.Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial.Second-line rescue therapy of helicobacter pylori infection."Rescue" regimens after Helicobacter pylori treatment failure.Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.Attempts to enhance the eradication rate of Helicobacter pylori infectionModification of drug delivery to improve antibiotic targeting to the stomach.High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland.Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.Should quinolones come first in Helicobacter pylori therapy?Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in TaiwanRescue Therapy for Helicobacter pylori Infection 2012.Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori.Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study.Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery.Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
P2860
Q28542458-69DAD769-937E-4F8A-A1B8-3D792F3C7312Q33372344-225D8347-7AFE-4B5E-8779-DCD199C2611AQ33678973-CB3F7CBE-8F37-4108-8D80-1FD711E19E36Q33843119-040FCDC0-259E-4B1A-BDBC-411094618DE5Q34409114-81B51BB0-0CE5-438C-86A5-8B6E274D07CDQ37273653-26D7079A-081D-4703-ACC4-E4580535714AQ38182087-2243A366-0B11-4231-BBC9-567C1984137FQ38200052-CB37ED04-6AA9-4284-907B-D082C4277330Q38212213-FCAC00A6-A093-4FF2-B2C4-FC284F197F9AQ38543395-981E5820-C18B-43AB-8304-B1BC7301DBC8Q40438856-EC7D5107-81D5-47BF-9CA7-97666EDD5917Q41733681-DAA17947-AD7B-444C-8058-3B0D3EFD0F8FQ41807465-483323AE-7405-4E13-B38B-709647882106Q41900168-00870531-1C9E-45B2-BC36-D7DB0C2CD6B9Q42129420-6FDA7970-8035-4C0E-B0EE-5EB0158333D3Q42270727-3C5EF392-5DC4-45E4-B69E-CFE92B04A4F2Q42905753-E92930C0-8612-45CE-A919-46DA030BF988Q44530388-72076167-E31E-4CBB-968D-6EBAE74BDD10Q57226378-8EB220FB-0FF2-4E9B-93EF-958DB6B30A37
P2860
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
7-day triple therapy of Helico ...... own antimicrobial sensitivity.
@en
7-day triple therapy of Helico ...... own antimicrobial sensitivity.
@nl
type
label
7-day triple therapy of Helico ...... own antimicrobial sensitivity.
@en
7-day triple therapy of Helico ...... own antimicrobial sensitivity.
@nl
prefLabel
7-day triple therapy of Helico ...... own antimicrobial sensitivity.
@en
7-day triple therapy of Helico ...... own antimicrobial sensitivity.
@nl
P2093
P2860
P1433
P1476
7-day triple therapy of Helico ...... own antimicrobial sensitivity.
@en
P2093
Christian Haferland
Christine Hänel
David Antos
Eberhard Meier
Ekkehard Bayerdörffer
Elke Bästlein
Friedrich Trump
Manfred Stolte
Michael Buchner
Norbert Lehn
P2860
P356
10.1111/J.0083-8703.2006.00375.X
P577
2006-02-01T00:00:00Z